Omada Health (OMDA) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $12.96, Omada Health (OMDA) es una empresa del sector Healthcare valorada en 764M. La acción obtiene una puntuación de 61/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 6 feb 2026Omada Health (OMDA) Resumen de Asistencia Médica y Tuberías
Omada Health revolutionizes chronic care with its virtual platform, delivering clinically validated programs for cardiometabolic disease, musculoskeletal care, and behavioral health, positioning itself as a leader in the rapidly expanding digital health market and offering a compelling investment in preventative healthcare solutions.
Tesis de Inversión
Omada Health presents a notable research candidate within the expanding virtual care market. The company's focus on chronic conditions, a significant and growing area of healthcare expenditure, positions it for sustained growth. With a gross margin of 64.2%, Omada demonstrates a strong ability to generate profit from its services. Key value drivers include the increasing adoption of virtual care, partnerships with major health plans and employers, and the potential for international expansion. The company's clinically validated programs and data-driven approach provide a competitive edge. Upcoming catalysts include further expansion of its program offerings and potential acquisitions to broaden its market reach. Investors may want to evaluate Omada's high beta of 6.84, indicating significant volatility, and negative P/E ratio of -24.24, reflecting current losses. However, the company's strong market position and growth potential make it an attractive investment.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Gross Margin of 64.2% indicates strong profitability potential in its virtual care programs.
- Market Cap of $0.69B reflects its current valuation in the competitive healthcare information services market.
- 849 employees signify a substantial operational capacity to support its virtual care delivery.
- Partnerships with leading health plans and employers drive user acquisition and revenue growth.
- Focus on chronic conditions positions Omada in a high-demand, high-growth segment of the healthcare market.
Competidores y Pares
Fortalezas
- Clinically validated programs with proven health outcomes.
- Strong partnerships with leading health plans and employers.
- Proprietary technology platform with data analytics capabilities.
- Focus on chronic conditions, a high-demand area of healthcare.
Debilidades
- Negative profit margin (-11.3%) indicates current lack of profitability.
- High beta (6.84) suggests significant stock price volatility.
- Reliance on partnerships for customer acquisition.
- Limited international presence.
Catalizadores
- Upcoming: Expansion into new chronic conditions, such as mental health or respiratory diseases, expected within the next 2-3 years.
- Ongoing: Increasing adoption of virtual care and digital health solutions, driven by rising healthcare costs and consumer demand.
- Ongoing: Strategic partnerships with health plans and employers to expand market reach.
- Upcoming: Potential acquisitions of smaller, innovative companies in the digital health space within the next 1-2 years.
Riesgos
- Potential: Intense competition in the virtual care market could erode market share and pricing power.
- Potential: Changes in healthcare regulations and reimbursement policies could negatively impact revenue.
- Ongoing: Data security and privacy concerns could damage reputation and lead to legal liabilities.
- Potential: Technological disruptions could render existing solutions obsolete.
- Ongoing: Negative profit margin (-11.3%) poses a risk to long-term financial sustainability.
Oportunidades de crecimiento
- Expansion into New Chronic Conditions: Omada can leverage its existing platform and expertise to develop programs for additional chronic conditions, such as mental health disorders or respiratory diseases. The market for mental health solutions alone is estimated to reach $53.6 billion by 2030, presenting a significant growth opportunity. Timeline: Within the next 2-3 years, Omada could launch new programs targeting these conditions, further diversifying its revenue streams.
- Strategic Partnerships and Acquisitions: Omada can pursue strategic partnerships with other healthcare providers, technology companies, or pharmaceutical firms to expand its reach and enhance its service offerings. Acquiring smaller, innovative companies in the digital health space could also provide access to new technologies and markets. Timeline: Ongoing, with potential acquisitions occurring within the next 1-2 years.
- International Expansion: Omada can extend its virtual care programs to international markets, where the demand for digital health solutions is growing rapidly. Europe and Asia-Pacific represent particularly attractive regions for expansion. Timeline: Within the next 3-5 years, Omada could establish a presence in select international markets, leveraging its proven business model and technology platform.
- Data Analytics and Personalization: Omada can further leverage data analytics to personalize its programs and improve patient outcomes. By analyzing patient data, the company can identify individual needs and tailor interventions accordingly. This enhanced personalization can lead to higher engagement rates and better health outcomes. Timeline: Ongoing, with continuous improvements to its data analytics capabilities.
- Integration with Wearable Devices and Remote Monitoring: Omada can integrate its platform with wearable devices and remote monitoring technologies to collect real-time data on patient health. This data can be used to provide more timely and personalized support, as well as to track the effectiveness of its programs. The market for wearable medical devices is projected to reach $29.7 billion by 2029. Timeline: Within the next 1-2 years, Omada could integrate with a wider range of wearable devices and remote monitoring technologies.
Oportunidades
- Expansion into new chronic conditions and therapeutic areas.
- Strategic partnerships and acquisitions to broaden service offerings.
- International expansion to new markets.
- Increased adoption of virtual care and digital health solutions.
Amenazas
- Intense competition in the virtual care market.
- Changes in healthcare regulations and reimbursement policies.
- Data security and privacy concerns.
- Potential for technological disruptions.
Ventajas competitivas
- Clinically validated programs with proven health outcomes.
- Proprietary technology platform with data analytics and personalization capabilities.
- Strong partnerships with leading health plans and employers.
- Established brand reputation in the virtual care market.
Acerca de OMDA
Founded with the mission to transform healthcare through technology, Omada Health has emerged as a leading virtual-care provider in the United States. The company addresses the growing prevalence of chronic conditions by offering clinically validated digital programs designed to improve health outcomes and reduce healthcare costs. Omada's programs cover a range of chronic conditions, including cardiometabolic disease (such as diabetes and hypertension), musculoskeletal care, and behavioral health. These programs are delivered digitally, providing patients with convenient access to personalized support and resources between traditional doctor visits. Omada Health's approach combines technology with human interaction, leveraging data analytics and behavioral science to create tailored interventions. The company's platform offers features such as remote monitoring, personalized coaching, and peer support, all aimed at empowering individuals to manage their health proactively. By focusing on prevention and early intervention, Omada Health seeks to mitigate the long-term health and financial burdens associated with chronic diseases. Headquartered in San Francisco, Omada Health has established partnerships with leading health plans, employers, and health systems across the country. The company's solutions are designed to integrate seamlessly into existing healthcare ecosystems, enhancing the overall care experience for patients and providers alike. As the demand for virtual care continues to grow, Omada Health is well-positioned to capitalize on its innovative platform and expand its reach to serve a broader population.
Qué hacen
- Provide virtual care programs for chronic conditions.
- Offer clinically validated programs for cardiometabolic disease.
- Deliver digital solutions for musculoskeletal care.
- Provide behavioral health support through a virtual platform.
- Offer personalized coaching and remote monitoring.
- Integrate technology with human interaction for tailored interventions.
- Partner with health plans, employers, and health systems.
Modelo de Negocio
- Subscription-based model, charging health plans and employers for access to its virtual care programs.
- Revenue generated per enrolled member per month (PEPM).
- Partnerships with health systems for integration into existing care pathways.
Contexto de la Industria
Omada Health operates within the rapidly evolving healthcare information services industry, driven by increasing demand for virtual care and digital health solutions. The market is experiencing significant growth, fueled by factors such as rising healthcare costs, an aging population, and advancements in technology. The competitive landscape includes companies like PGNY, BCRX, MAZE, OMCL, and PHR, each offering various digital health solutions. Omada differentiates itself through its focus on clinically validated programs for chronic conditions and its partnerships with established healthcare providers. As the industry continues to embrace digital transformation, Omada is well-positioned to capture a significant share of the market.
Clientes Clave
- Health plans seeking to improve member health outcomes and reduce costs.
- Employers looking to provide employees with convenient access to chronic care management.
- Health systems aiming to expand their reach and enhance patient engagement.
Finanzas
Gráfico e información
Precio de la acción de Omada Health (OMDA): $12.96 (-0.44, -3.28%)
Últimas noticias
-
How The Omda (OB:OMDA) Investment Story Is Shifting As Analyst Expectations Reset
Yahoo! Finance: OMDA News · 25 mar 2026
-
Omada Appoints Jakob H. Kraglund as CEO to Accelerate Global Growth
Yahoo! Finance: OMDA News · 18 mar 2026
-
Wall Street Analysts Believe Omada Health, Inc. (OMDA) Could Rally 59.53%: Here's is How to Trade
zacks.com · 16 mar 2026
-
Could This $14 Stock Be Your Ticket to Millionaire Status?
fool.com · 14 mar 2026
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para OMDA.
Objetivos de Precios
Objetivo de consenso: $23.50
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de OMDA en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Competidores y Pares
Últimas Noticias
How The Omda (OB:OMDA) Investment Story Is Shifting As Analyst Expectations Reset
Omada Appoints Jakob H. Kraglund as CEO to Accelerate Global Growth
Wall Street Analysts Believe Omada Health, Inc. (OMDA) Could Rally 59.53%: Here's is How to Trade
Could This $14 Stock Be Your Ticket to Millionaire Status?
Acciones de Omada Health: Preguntas Clave Respondidas
¿Cuáles son los factores clave para evaluar OMDA?
Omada Health (OMDA) actualmente tiene una puntuación IA de 61/100, indicando puntuación moderada. Los analistas apuntan a $23.50 (+81% desde $12.96). Fortaleza clave: Clinically validated programs with proven health outcomes.. Riesgo principal a monitorear: Potential: Intense competition in the virtual care market could erode market share and pricing power.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de OMDA?
OMDA actualmente puntúa 61/100 (Grado B) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de OMDA?
Los precios de OMDA se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre OMDA?
Los analistas han establecido un precio objetivo de consenso de $23.50 para OMDA, representando un potencial alcista del 81% desde el precio actual de $12.96. La cobertura incluye calificaciones de compra, mantener y venta, estimaciones de ganancias y recientes mejoras o rebajas. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en OMDA?
Las categorías de riesgo para OMDA incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Intense competition in the virtual care market could erode market share and pricing power.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de OMDA?
La relación P/E para OMDA compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está OMDA sobrevalorada o infravalorada?
Determinar si Omada Health (OMDA) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Objetivo de analistas $23.50 (+81% desde el precio actual). Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de OMDA?
Omada Health (OMDA) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data is based on the most recent available information. The virtual care market is subject to rapid change and evolving regulations.